| 1 |
34952963 | Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects. | 2022 Feb |
1 |
| 2 |
31900084 | Unravelling the interaction of glipizide with human serum albumin using various spectroscopic techniques and molecular dynamics studies. | 2021 Jan |
1 |
| 3 |
31709648 | The presence of two reduced function variants in CYP2C9 influences the acute response to glipizide. | 2020 Dec |
1 |
| 4 |
29844095 | Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas. | 2018 Aug |
1 |
| 5 |
29245957 | Glipizide sensitizes lung cancer cells to TRAIL-induced apoptosis via Akt/mTOR/autophagy pathways. | 2017 Nov 21 |
1 |
| 6 |
25812009 | The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes. | 2015 |
1 |
| 7 |
26548081 | Interaction of mouse intestinal P-glycoprotein with oral antidiabetic drugs and its inhibitors. | 2015 Sep |
1 |
| 8 |
23657947 | The effects of sulfonylureas plus metformin on lipids, blood pressure, and adverse events in type 2 diabetes: a meta-analysis of randomized controlled trials. | 2013 Dec |
1 |
| 9 |
23953891 | Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus. | 2013 Dec |
2 |
| 10 |
23672754 | Effects and patient compliance of sustained-release versus immediate-release glipizides in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. | 2011 Nov |
1 |
| 11 |
18280440 | A comparative study of the glycemic control of various antidiabetic agents and the role of homocysteine in the therapy of type 2 diabetes mellitus. | 2008 Mar-Apr |
1 |
| 12 |
19033001 | Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): study design and baseline characteristics. | 2008 Dec |
1 |
| 13 |
16704555 | Long-term beneficial effects of glipizide treatment on glucose tolerance in subjects with impaired glucose tolerance. | 2006 Jun |
3 |
| 14 |
15133754 | Effects of glipizide GITS and glibenclamide on metabolic control, hepatic glucose production, and insulin secretion in patients with type 2 diabetes. | 2004 May-Jun |
1 |
| 15 |
12759885 | Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action. | 2003 May |
1 |
| 16 |
12795025 | [Oral antidiabetic therapy and cardiovascular complications: theoretical problem or clinical evidence?]. | 2003 Apr 6 |
1 |
| 17 |
12852706 | Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea. | 2003 Mar |
1 |
| 18 |
14565810 | Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus. | 2003 Nov |
1 |
| 19 |
12453952 | Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues. | 2002 Dec |
2 |
| 20 |
10605995 | Oral pharmacologic management of type 2 diabetes. | 1999 Dec |
1 |
| 21 |
9649951 | Combination insulin and sulfonylurea therapy in insulin-requiring type 2 diabetes mellitus. | 1998 Mar |
5 |
| 22 |
9096986 | Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group. | 1997 Apr |
1 |
| 23 |
9167112 | Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM. | 1997 Jun |
1 |
| 24 |
9463023 | [Pharmacokinetics of hypoglycemic sulfonamides: Ozidia, a new concept]. | 1997 Nov |
1 |
| 25 |
8842609 | The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM. | 1996 Aug |
1 |
| 26 |
8848822 | The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus. | 1996 Feb |
2 |
| 27 |
8888072 | The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus. | 1996 Sep-Oct |
5 |
| 28 |
8894498 | Oral antidiabetic drugs: an overview. | 1996 Sep |
1 |
| 29 |
7662219 | Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance. | 1995 May |
1 |
| 30 |
8750768 | A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin. | 1995 Dec |
5 |
| 31 |
7697692 | Effect of insulin-glipizide combination on skeletal muscle capillary basement membrane width in diabetic patients. | 1994 Nov-Dec |
4 |
| 32 |
7882817 | Comparative efficacy of a once-daily controlled-release formulation of glipizide and immediate-release glipizide in patients with NIDDM. | 1994 Dec |
4 |
| 33 |
7908257 | Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84.0418 in healthy subjects. | 1994 Mar |
2 |
| 34 |
8043894 | Effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (GLUT 4) and glycogen synthase activity during hyperglycaemia in type 2 diabetic patients. | 1994 Apr |
2 |
| 35 |
8112188 | Long-term randomized placebo-controlled double-blind therapeutic comparison of glipizide and glyburide. Glycemic control and insulin secretion during 15 months. | 1994 Jan |
3 |
| 36 |
8025207 | The use of glipizide combined with intensive insulin treatment for the induction of remissions in new onset adult type I diabetes. | 1993 |
1 |
| 37 |
8240415 | Increase in insulin binding and inhibition of the decrease in the phospholipid content of human term placental homogenates in culture by the sulfonylurea glipizide. | 1993 Nov 2 |
1 |
| 38 |
8378744 | The relationship between early insulin release and glucose tolerance in healthy subjects. | 1993 Jul |
3 |
| 39 |
8403824 | The acute effect of preprandial exogenous and endogenous sulphonylurea-stimulated insulin secretion on postprandial glucose excursions in patients with type 2 diabetes. | 1993 Aug-Sep |
1 |
| 40 |
8417634 | What is the benefit of increasing the sulfonylurea dose? | 1993 Feb 1 |
1 |
| 41 |
1521732 | Expression of the 64 kDa/glutamic acid decarboxylase rat islet cell autoantigen is influenced by the rate of insulin secretion. | 1992 May |
1 |
| 42 |
1541320 | Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitus. | 1992 |
1 |
| 43 |
1777653 | Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study. | 1991 |
6 |
| 44 |
1826242 | Changes in carbohydrate metabolism in association with glipizide treatment of type 2 diabetes. | 1991 Jan |
1 |
| 45 |
1943745 | Improvement of glucose-primed intravenous glucose tolerance and correction of acute insulin decrement by glipizide in type II diabetes. | 1991 Nov |
1 |
| 46 |
1988239 | Enhancement of absorption and effect of glipizide by magnesium hydroxide. | 1991 Jan |
1 |
| 47 |
2137755 | Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients. | 1990 Feb |
4 |
| 48 |
2196193 | [Effect of glipizide on glycemic control and peripheral insulin sensitivity in type 1 diabetics]. | 1990 Mar-Apr |
1 |
| 49 |
2209345 | Will sulfonylurea treatment of impaired glucose tolerance delay development and complications of NIDDM? | 1990 Aug |
1 |
| 50 |
2642663 | Effect of glipizide on the surgically altered pancreas. | 1989 Jan |
1 |